STOCK TITAN

Caris Life Sciences (CAI) investor group reports 11.3M shares, or 4.0% ownership

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Caris Life Sciences, Inc. received an updated passive ownership report from investment entities affiliated with J.H. Whitney. J.H. Whitney VI, L.P., together with J.H. Whitney Equity Partners VI, LLC, and managing members Paul R. Vigano and Robert M. Williams, Jr., report beneficial ownership of 11,256,615 shares of Caris common stock.

This position represents 4.0% of the outstanding common stock, with shared voting and dispositive power over all reported shares and no sole voting or dispositive power. The filing states that no other person has the right to receive, or direct the receipt of, dividends or sale proceeds from these securities. The amendment confirms that the reporting group now holds 5 percent or less of the class.

Positive

  • None.

Negative

  • None.
Shares beneficially owned 11,256,615 shares Common stock beneficially owned by the J.H. Whitney reporting group
Percent of class 4.0% Percentage of Caris Life Sciences common stock beneficially owned
Shared voting power 11,256,615 shares Shares over which the reporting persons share voting power
Shared dispositive power 11,256,615 shares Shares over which the reporting persons share dispositive power
Sole voting power 0 shares Shares with sole voting power reported by the group
Sole dispositive power 0 shares Shares with sole dispositive power reported by the group
beneficially owned financial
"Item 4. | Ownership (a) | Amount beneficially owned: 11,256,615"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting power financial
"Shared Voting Power 11,256,615.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power financial
"Shared Dispositive Power 11,256,615.00"
percent of class financial
"Percent of class: 4.0%"
Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.

FAQ

What ownership stake in Caris Life Sciences (CAI) does J.H. Whitney report?

The reporting group holds 11,256,615 shares of Caris Life Sciences common stock, representing 4.0% of the outstanding class, with shared voting and dispositive power over all of these shares.

Who are the reporting persons in this Caris Life Sciences (CAI) Schedule 13G/A?

The filing is made on behalf of J.H. Whitney VI, L.P., its general partner J.H. Whitney Equity Partners VI, LLC, and managing members Paul R. Vigano and Robert M. Williams, Jr. as the reporting persons.

What percentage of Caris Life Sciences (CAI) does the J.H. Whitney group own?

The reporting group discloses beneficial ownership of 4.0% of Caris Life Sciences common stock, corresponding to 11,256,615 shares with shared voting and shared dispositive power.

Does any other party share in dividends or sale proceeds from the J.H. Whitney Caris (CAI) stake?

The filing states that no other person has the right to receive, or direct the receipt of, dividends from, or proceeds from the sale of, the securities owned by J.H. Whitney VI, L.P..

What does the '5 percent or less' disclosure mean for Caris Life Sciences (CAI)?

The ownership section affirms that the reporting group now holds 5 percent or less of Caris Life Sciences’ common stock, while still reporting 11,256,615 shares, or 4.0% of the class.

What voting and dispositive powers are reported over Caris Life Sciences (CAI) shares?

The reporting persons have 0 shares with sole voting or dispositive power and 11,256,615 shares with shared voting and shared dispositive power over Caris Life Sciences common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





142152107

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



J H Whitney VI L P
Signature:/s/ Paul R. Vigano
Name/Title:Paul R. Vigano, Managing Member of J.H. Whitney Equity Partners VI, LLC, its General Partner
Date:08/12/2026
J. H. Whitney Equity Partners VI, LLC
Signature:/s/ Paul R. Vigano
Name/Title:Paul R. Vigano, Managing Member
Date:08/12/2026
VIGANO PAUL R
Signature:/s/ Paul R. Vigano
Name/Title:Paul R. Vigano
Date:08/12/2026
WILLIAMS ROBERT M JR
Signature:/s/ Robert M. Williams, Jr.
Name/Title:Robert M. Williams, Jr.
Date:08/12/2026